Sepigel 305 is a polyacrylamide based chrism and
rheology modifier that allows you to actualize oil chargeless emulsions as
able-bodied as fast and simple O/W lotions, creams and even blubbery physique
adulate bases. Sepigel 305 is a actual agnate blazon of chrism arrangement used
in nationally accepted anti-acne products. Sepigel 305 can actualize light, oil
free, fast breaking lotions and skincare treatments for acute derma types, or
ablaze lotions used as a carrier for added actives. Sepigel 305 is absolutely a
fantasic chrism and balm authoritative apparatus for specialized needs, or even
to actualize low amount O/W and W/O balm formulations. Sepigel 305 at 2% acceptance
creates absolute balm viscosity, 3% creates thicker creams, and 5% acceptance
facilitates luxurious, non anointed physique adulate artefact creation.
Sepigel 305 acts as a agglomeration and emulsifying
agent, which comes in a liquid, actual simple to handle form. Sepigel 305
contributes a luxurious, top end buttery feel to your formulations. Sepigel 305
requires neither premixing, nor top amount of shear, nor neutralization.
Sepigel 305 can be used to emulsify all types of oil phases afterwards heating
(completely algid process, thereby attention the allowances of brittle actives,
vitamins, and botanical extracts), bearing gel-creams with a rich, cottony
arrangement that are simple to administer and rapidly captivated by the skin.
Sepigel 305 will emulsify dimethicone, cyclomethicone,
PEG-8, IPM, and even top levels of glycerin. Sepigel 305 will emulsify
anhydrous liquids such as acetone (gelled attach brightness remover), alcohols
(creating gelled cologne aftershaves and lady's afterwards barber leg moisturizers),
and glycerin (for affable lubrication gels). Sepigel 305 aswell allows for
formulating over a ample pH spectrum. Sepigel 305 is actual simple to use, just
artlessly add to your accustomed balm or chrism conception afterwards bond oil
and baptize phases to adapt adherence and enhance the rheology (texture) of
your own formulations.
No comments:
Post a Comment